drugset
Drugs / MF59 adjuvanted H5N1 influenza vaccine
last change Feb 2009 re-read 3 minutes ago

MF59 adjuvanted H5N1 influenza vaccine

also known as MF59-H5N1 vaccine

Vaccine

Developed for
influenza
Investigated by
Novartis Vaccines

Trials 1

today NCT00382187 · Ph 2
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00382187 Nov 2006 → Jan 2008 influenza Novartis Vaccines Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as MF59 adjuvanted H5N1 influenza vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00382187 ↗
Known as MF59-H5N1 vaccine “Only the MF59-H5N1 vaccine induced high titers of neutralizing antibodies” PMID 19237568 ↗ Feb 2009
Modality Vaccine “plain or MF59-adjuvanted H5N1 subunit vaccines” PMID 19237568 ↗ Feb 2009